Herman Otten voted Nay (Passage) on this Legislation.
Title: Expands the Ability for Patients to Seek Investigational Drugs, Biological Products, or Devices
Vote to pass a bill that expands the ability for patients to seek investigational drugs, biological products, or devices.
Defines “serious illness” as “any disease, medical condition, or surgical condition that entails extreme pain, permanent disability, or a condition that is considered by a treating physician to not be reversible even with administration of current federally approved and available treatments” (Sec. 34-51-1).
Establishes difference between advanced (progressive, potentially terminal) and serious (not necessarily terminal) illnesses (Sec. 34-51-1).
Requires treating physicians rule out alternative treatments, in addition to FDA-approved, prior to seeking investigational drugs (Sec. 34-51-3(2)).
Requires treating physicians attest that investigational drugs may “possibly” (amended from “likely”) improve patient life expectancy, prognosis (Sec. 34-51-3(2)).
Title: Expands the Ability for Patients to Seek Investigational Drugs, Biological Products, or Devices
Vote to pass a bill that expands the ability for patients to seek investigational drugs, biological products, or devices.
Defines “serious illness” as “any disease, medical condition, or surgical condition that entails extreme pain, permanent disability, or a condition that is considered by a treating physician to not be reversible even with administration of current federally approved and available treatments” (Sec. 34-51-1).
Establishes difference between advanced (progressive, potentially terminal) and serious (not necessarily terminal) illnesses (Sec. 34-51-1).
Requires treating physicians rule out alternative treatments, in addition to FDA-approved, prior to seeking investigational drugs (Sec. 34-51-3(2)).
Requires treating physicians attest that investigational drugs may “possibly” (amended from “likely”) improve patient life expectancy, prognosis (Sec. 34-51-3(2)).
Title: Expands the Ability for Patients to Seek Investigational Drugs, Biological Products, or Devices